EHRs are valuable tools in clinical trials and cancer research. They facilitate the identification of eligible patients for clinical trials by enabling researchers to search for specific criteria within large patient populations. Additionally, EHRs can streamline data collection and improve the accuracy of research data, thus accelerating the discovery of new treatments and advancing our understanding of cancer biology.
